Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Post-COVID-19 changes in the epidemiology of group A Streptococcus infections in Taiwan: A retrospective study.

Created on 17 Oct 2026

Authors

Wai-Ki Goh, Yun-Chung Liu, Ya-Li Hu, Shu-Yuan Ho, Yu-Tsung Huang, Chun-Yi Lu, Hung-Jen Tang, Li-Min Huang, Tu-Hsuan Chang, Luan-Yin Chang

Published in

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

Temporal changes in group A Streptococcus (GAS) infections have been reported worldwide, but long-term data from Taiwan remain limited. This study evaluated temporal patterns, age-specific disease characteristics, antimicrobial susceptibility, and factors associated with invasive GAS infection.
We conducted a retrospective study that included patients with GAS infection at a tertiary referral center in Taiwan from 2015 to 2024. Monthly hospital-identified case counts were described, and multivariable logistic regression was used to identify factors associated with invasive disease.
Among 454 patients, 33 (7.3%) had invasive disease. Monthly case counts declined markedly during the COVID-19 period (2020-2022), remained low in 2023, and increased to 45 cases in 2024, still below pre-pandemic annual levels. Adults aged ≥65 years accounted for 14 of 33 invasive cases (42.4%). Age ≥18 years (adjusted odds ratio [aOR], 11.6; 95% confidence interval [CI], 4.4-30.9; p < 0.001) and the presence of two or more underlying disease categories (aOR, 29.7; 95% CI, 10.4-84.5; p < 0.001) were associated with invasive disease. All isolates were susceptible to penicillin. Invasive isolates showed higher susceptibility to clindamycin and erythromycin but lower susceptibility to tetracycline than noninvasive isolates.
Hospital-identified GAS cases showed substantial temporal variation. Older age and greater underlying disease burden were associated with invasive infection. These findings may support clinical risk assessment and institutional surveillance.

PMID:
42888059
Bibliographic data and abstract were imported from PubMed on 17 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement